EasiBioArmour. Development and production of a surgical gown with enhanced antiviral and antibacterial properties which is bio-based and biodegradable

传染病的传播在世界范围内继续增长，人畜共患病原体向人类转移的风险增加。最近的新冠肺炎全球大流行给个人防护装备（PPE）（特别是手术衣）带来了供应链挑战，导致NHS和其他医疗保健人员没有足够的防护装备，这些防护装备既舒适，又能提供有效的抗病毒屏障，而且对NHS和其他医疗保健机构来说价格合理。医院和诊所使用的大多数防护服设计为一次性使用即可丢弃。这些都是用石化合成纤维(例如。聚丙烯、聚酯和聚乙烯)。这就产生了生产一种具有增强抗病毒/抗菌性能的手术衣的想法，这种手术衣使用生物基和可生物降解的可持续材料生产。利纳姆制药有限公司正在与非织造布创新和研究所合作，开发一种使用生物基和可生物降解的可持续材料增强抗病毒和抗菌性能的手术服。

The spread of infectious diseases continues to grow worldwide, with increased risks of zoonotic based pathogens transferring to humans. The recent global pandemic of nCOVID-19 has led to supply chain challenges for personal protective equipment (PPE) in particular surgical gowns leading to NHS and other healthcare staff having insufficient protective equipment which is comfortable, provides an effective antiviral barrier, and at an affordable cost to the NHS and other healthcare institutions.The majority of gowns used in hospitals and clinic settings are designed to be discarded after single use. These are produced using petrochemical based synthetic fibres (eg. polypropylene, polyester and polyethylene). This led to the idea of producing a surgical gown which has enhanced antiviral/antibacterial properties and is produced using bio-based and biodegradable sustainable material.Lynam Pharma Limited is working with the Nonwovens Innovation and Research Institute to develop a surgical gown which has enhanced antiviral and antibacterial properties using bio-based and biodegradable sustainable materials.